Occudo Quantitative Strategies LP Cytokinetics Inc Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$47.86 - $75.05 $316,354 - $496,080
6,610 New
6,610 $358,000
Q4 2023

Feb 14, 2024
BUY
$26.88 - $83.49 $423,736 - $1.32 Million
15,764 New
15,764 $1.32 Million
Q2 2022

Aug 15, 2022
SELL
$33.93 - $48.92 $257,392 - $371,107
-7,586 Reduced 25.34%
22,347 $878,000
Q1 2022

May 16, 2022
BUY
$29.74 - $46.0 $88,773 - $137,310
2,985 Added 11.08%
29,933 $1.1 Million
Q4 2021

Feb 14, 2022
SELL
$34.35 - $46.38 $95,870 - $129,446
-2,791 Reduced 9.38%
26,948 $1.23 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $551,361 - $1.06 Million
29,739 New
29,739 $1.06 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.76B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email